Toronto - Delayed Quote CAD
Cardiol Therapeutics Inc. (CRDL.TO)
1.4900
-0.0100
(-0.67%)
At close: April 25 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 3.31M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Chao (Jennifer M) Director of Issuer | -- | Direct | -- | Apr 8, 2025 |
| Torreamione (Guilermo) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.26 per share. | Direct | 21,722 | Dec 26, 2024 |
| Hamer (Andrew Warwick M.D.) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.31 per share. | Direct | 24,721 | Dec 19, 2024 |
| Torreamione (Guilermo) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.45 per share. | Direct | 1,332 | Dec 18, 2024 |
| Lim (Bernard) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.36 per share. | Direct | 13,630 | Dec 17, 2024 |
| Pekos (Peter) Director of Issuer | Acquisition or disposition in the public market at price 1.29 per share. | Indirect | 49,987 | Dec 17, 2024 |
| Torreamione (Guilermo) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.31 per share. | Direct | 26,003 | Dec 17, 2024 |
| Elsley (David) Director of Issuer | Acquisition or disposition in the public market at price 1.32 per share. | Direct | 52,720 | Dec 16, 2024 |
| Torreamione (Guilermo) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.34 per share. | Direct | 999 | Dec 16, 2024 |
| Waddick (Christopher James) Director of Issuer | Acquisition or disposition in the public market at price 1.35 per share. | Direct | 34,887 | Dec 16, 2024 |
| Hamer (Andrew Warwick M.D.) Senior Officer of Issuer | -- | Direct | -- | Oct 25, 2024 |
| Chao (Jennifer M) Director of Issuer | -- | Direct | -- | Sep 6, 2024 |
| Hamer (Andrew Warwick M.D.) Senior Officer of Issuer | -- | Direct | -- | Sep 6, 2024 |
| Loxam (Teri) Director of Issuer | -- | Direct | -- | Sep 6, 2024 |
| Willner (Michael Jay) Director of Issuer | -- | Direct | -- | Sep 6, 2024 |
| Torreamione (Guilermo) Senior Officer of Issuer | -- | Direct | -- | Jul 3, 2024 |
| Elsley (David) Director of Issuer | Acquisition or disposition in the public market at price 2.03 per share. | Direct | 101,450 | Jun 24, 2024 |
Related Tickers
MDP.TO Medexus Pharmaceuticals Inc.
2.7000
-2.53%
GHG.CN Global Hemp Group Inc.
0.0200
0.00%
DHB.V Delivra Health Brands Inc.
0.1800
+12.50%
BHC.TO Bausch Health Companies Inc.
7.53
-0.66%
TLRY.TO Tilray Brands, Inc.
0.6900
+1.47%
CL.CN Cresco Labs Inc.
1.1800
+7.27%
PLTH.CN Planet 13 Holdings Inc.
0.4000
+11.11%
AYR-A.CN Ayr Wellness Inc.
0.3250
0.00%
RDY Dr. Reddy's Laboratories Limited
13.79
-1.50%
LABS.TO MediPharm Labs Corp.
0.0900
0.00%